Results 101 to 110 of about 16,889 (275)
Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study
Brain Sciences, 2019 Background: Safinamide is an approved drug for the treatment of motor fluctuations of Parkinson’s Disease (PD) patients with a potential benefit on non-motor symptoms (NMS).
Gloria Martí-Andrés +6 more
doaj +1 more source
Effects of topiramate on oral dyskinesia induced by reserpine
, 2004 Recently, we have described the antidyskinetic property of the GABA mimetic drug valproic acid on reserpine-induced oral dyskinesia, an animal model that has been related to tardive as well as acute dyskinesias, which are associated with important ...
Silva, R. H. +11 more
core +1 more source
Orofacial Drinking Tremor: A Case Series and Literature Review
Movement Disorders Clinical Practice, EarlyView.Abstract Background Task‐specific orofacial tremor is a rare condition in which rhythmic oscillations of orofacial muscles occur during specific actions. Drinking tremor represents a recurrent pattern in isolated reports, although its phenomenology and underlying mechanisms remain incompletely defined.
Daniele Birreci +7 more
wiley +1 more source
Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia
, 2017 L-3,4-Dihydroxyphenylalanine (L-DOPA) is the most effective drug in the symptomatic treatment of Parkinson's disease, but chronic use is associated with L-DOPA-induced dyskinesia in more than half the patients after 10 years of treatment.
Havelund, Jesper F; id_orcid +15 more
core +1 more source
Severity‐Based and Family‐Centered Approaches to Deep Brain Stimulation in GNAO1‐Related Disorders
Movement Disorders Clinical Practice, EarlyView.
Jana Domínguez‐Carral +1 more
wiley +1 more source
Surgical Treatment of Dyskinesia in Parkinson’s Disease
Frontiers in Neurology, 2014 One of the main indications for stereotactic surgery in Parkinson’s disease (PD) is the control of levodopa induced dyskinesia. This can be achieved by by pallidotomy and globus pallidus internus (GPi) deep brain stimulation (DBS) or by subthalamotomy ...
Renato Puppi Munhoz +2 more
doaj +1 more source
Stratification of the risk of developing tardive drug-induced complications
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018 Tardive drug dystonia / dyskinesia is one of the rare, and at the same time, the most severe motor complications associated with the use of pharmacological drugs. Complex assessment of risk factors for the development of tardive drug-induced side effects
L. A. Khublarova +2 more
doaj
AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys
, 2000 OBJECTIVE: To evaluate the contribution of amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) glutamate receptors to the pathogenesis of parkinsonian signs and levodopa-induced dyskinesias. BACKGROUND: Motor fluctuations and dyskinesias reflect,
Blanchet, P. J. +4 more
core
Refractory Motor Complications: Towards a Pragmatic Definition
Movement Disorders Clinical Practice, EarlyView.
Georg Ebersbach, Tobias Warnecke
wiley +1 more source
Movement Disorders in Developmental and Epileptic Encephalopathies
Movement Disorders Clinical Practice, EarlyView.Abstract Background Monogenic developmental and epileptic encephalopathies (DEE) frequently feature co‐occurring movement disorders. Gene discovery has expanded epilepsy‐dyskinesia syndromes (EDS) from classic associations such as stereotypies in Rett syndrome to PRRT2‐related infantile seizures with paroxysmal dyskinesia and crouched gait in SCN1A ...
Shekeeb Mohammad +2 more
wiley +1 more source